DoH Policies screened during the period - 1 July 2025 – 30 September 2025
Date published:
In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact.
Documents
- Regional Obesity Management Services (Northern Ireland) Consultation (PDF 595KB)
- Equality Screening Regional Review of Neurology Services (PDF 391KB)
- Amendments to the Safeguarding Vulnerable Groups (Northern Ireland) Order 2007 (315KB)
- NICE Technology Appraisal TA1071 - Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer (review of TA823) (302KB)
- NICE Technology Appraisal TA1074 - Sparsentan for treating primary IgA nephropathy (300KB)
- NICE Technology Appraisal TA1073 - Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies (307KB)
- NICE Technology Appraisal TA1077 - Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over (304KB)
- NICE Technology Appraisal TA1075 - Dapagliflozin for treating chronic kidney disease (review of TA775) (331KB)
- NICE Technology Appraisal TA1081 - Zanubrutinib for treating relapsed or refractory mantle cell lymphoma (300KB)
- Closure of GP Branch Surgery at Vere Foster Medical Practice, 475 Falls road, Belfast (331KB)
- NICE Technology Appraisal TA1079 - Fruquintinib for previously treated metastatic colorectal cancer
- NICE Technology Appraisal TA1085 - Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and over (302KB)
- NICE Clinical Guideline NG249 - Falls assessment and prevention in older people and in people 50 and over at higher risk (380KB)
- Northern Ireland Fostering Services Minimum Standards (366KB)
- Northern Ireland Children and Young People’s Plan 2025-2028 (1,745KB)
- Subordinate legislation amendments The Human Trafficking and Exploitation (Criminal Justice and Support for Victims) (Independent Guardian) Regulations (Northern Ireland) 2016 (the 2016 Regulations) (408KB)
- NICE Technology Appraisal TA1088 - Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over (300KB)
- The move of Lurgan Medical Practice, Moore’s Lane, Lurgan to Brownlow Health Centre site (312KB)
- NICE Technology Appraisal TA1087 - Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen (300KB)
- NICE Technology Appraisal TA1086 - Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor positive HER2-negative early breast cancer at high risk of recurrence (299KB)
- Further roll out of Multi-Disciplinary Teams (MDTs) in Primary Care (482KB)
- NICE Technology Appraisal TA1090 - Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma (300KB)
- NICE Technology Appraisal TA1091 - Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatments (301KB)
- Revised Code of Practice (“the Code”) to the Mental Health (Northern Ireland) Order 1998 (340KB)
- NICE Technology Appraisal TA1092 - Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer (309KB)
- NICE Technology Appraisal TA1094 - Guselkumab for treating moderately to severely active ulcerative colitis (320KB)
- The Provision of an Advocacy Service for dDeaf, dDeafblind and Hard of Hearing Adults (567KB)
- NICE Technology Appraisal TA1095 - Guselkumab for previously treated moderately to severely active Crohns disease (320KB)
- NICE Technology Appraisal TA1096 - Benralizumab for treating relapsing or refractory eosinophilic granulomatosis with polyangiitis (301KB)
- NICE Technology Appraisal TA1097 - Enfortumab vedotin with pembrolizumab for untreated unrespectable or metastatic urothelial cancer when platinum-based chemotherapy is suitable (301KB)
- Proposals to make amendments to the registration and inspection requirements imposed by HSC Trusts upon registered childcare providers in Northern Ireland (389KB)
- Closure of GP Branch Surgery at Dr Crossin, Higgins & McMullan Practice, 1a Norfolk Parade (346KB)
- NICE Technology Appraisal TA1093 - Idebenone for treating visual impairment in Lebers hereditary optic neuropathy in people 12 years and over (300KB)
- NICE Technology Appraisal TA1080 - Mirikizumab for previously treated moderately to severely active Crohn's disease (301KB)
- Pathology Blueprint Programme - Equality Impact Assessment (665KB)